Data Sheet 2_Efficacy and safety of Chinese botanical drug decoctions for migraine: a Baye

57 randomized controlled trials involving 6,005 patients were analyzed in this Bayesian network meta-analysis comparing Chinese botanical drug decoctions for migraine. The study, authored by Fan Zhang and uploaded to figshare in 2026, includes results from a systematic review of seven databases up to October 2025. It ranks interventions like Sanpian Decoction and Tongqiao Huoxue Decoction based on efficacy and safety outcomes.

Use Cases

• Comparing treatment efficacy for migraine pain intensity based on Visual Analog Scale scores
• Ranking interventions for reducing headache frequency and duration based on the meta-analysis results
• Applying Bayesian network meta-analysis methods using the described R software and gemtc package workflow
• Assessing the safety profile of different Chinese botanical drug decoctions from aggregated clinical trial data

Strengths

• Analysis is based on 57 randomized controlled trials, providing a substantial evidence base
• Systematic search covered seven major databases including PubMed, Embase, and Chinese sources
• The Bayesian model used 50,000 iterations with a 20,000 burn-in period to ensure convergence

Limitations

• The dataset is a 674.8 KB DOCX file; the underlying structured data (e.g., raw trial data) is not directly available
• Column-level documentation is absent; field semantics must be inferred from the manuscript text
• The authors note findings should be interpreted with caution due to variability in study quality

Provenance

Source

Systematic review and meta-analysis conducted by author Fan Zhang, shared via figshare.

Collection Method

Bayesian network meta-analysis of randomized controlled trials using R and the gemtc package.

Time Range

Trials from database inception to 20 October 2025.

Freshness

Last updated 2026-05-01 05:24:32